UBS Group’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $73.4M | Buy |
1,645,511
+1,006,583
| +158% | +$47.7M | 0.01% | 1374 |
|
|
2026
Q1 | $33M | Buy |
638,928
+227,599
| +55% | +$15.9M | ﹤0.01% | 2074 |
|
|
2025
Q4 | $37.9M | Sell |
411,329
-56,407
| -12% | -$5.4M | 0.01% | 1930 |
|
|
2025
Q3 | $34.7M | Buy |
467,736
+37,042
| +9% | +$3.75M | 0.01% | 1998 |
|
|
2025
Q2 | $55.9M | Sell |
430,694
-54,485
| -11% | -$7.9M | 0.01% | 1413 |
|
|
2025
Q1 | $77.3M | Buy |
485,179
+121,624
| +33% | +$22M | 0.01% | 1102 |
|
|
2024
Q4 | $67.4M | Buy |
363,555
+308,412
| +559% | +$59.9M | 0.01% | 1205 |
|
|
2024
Q3 | $11.6M | Sell |
55,143
-2,661
| -5% | -$462K | ﹤0.01% | 2231 |
|
|
2024
Q2 | $7.74M | Buy |
57,804
+25,617
| +80% | +$4.85M | ﹤0.01% | 2451 |
|
|
2024
Q1 | $6.91M | Sell |
32,187
-986
| -3% | -$193K | ﹤0.01% | 2620 |
|
|
2023
Q4 | $6.75M | Buy |
33,173
+2,366
| +8% | +$383K | ﹤0.01% | 2448 |
|
|
2023
Q3 | $6.11M | Sell |
30,807
-3,378
| -10% | -$852K | ﹤0.01% | 2386 |
|
|
2023
Q2 | $11.1M | Sell |
34,185
-14,102
| -29% | -$4.03M | ﹤0.01% | 1892 |
|
|
2023
Q1 | $11.3M | Buy |
48,287
+7,656
| +19% | +$1.94M | ﹤0.01% | 1805 |
|
|
2022
Q4 | $10.2M | Buy |
40,631
+24,747
| +156% | +$5.28M | ﹤0.01% | 1913 |
|
|
2022
Q3 | $2.82M | Buy |
15,884
+1,214
| +8% | +$244K | ﹤0.01% | 2850 |
|
|
2022
Q2 | $2.68M | Sell |
14,670
-6,922
| -32% | -$1.38M | ﹤0.01% | 2897 |
|
|
2022
Q1 | $5.54M | Buy |
21,592
+1,925
| +10% | +$440K | ﹤0.01% | 2437 |
|
|
2021
Q4 | $4.52M | Buy |
19,667
+5,111
| +35% | +$1.25M | ﹤0.01% | 2932 |
|
|
2021
Q3 | $3.39M | Sell |
14,556
-349
| -2% | -$72.8K | ﹤0.01% | 3100 |
|
|
2021
Q2 | $2.88M | Sell |
14,905
-1,302
| -8% | -$258K | ﹤0.01% | 3220 |
|
|
2021
Q1 | $3.35M | Buy |
16,207
+1,216
| +8% | +$258K | ﹤0.01% | 3016 |
|
|
2020
Q4 | $2.82M | Sell |
14,991
-347
| -2% | -$56.7K | ﹤0.01% | 3046 |
|
|
2020
Q3 | $1.98M | Sell |
15,338
-4,403
| -22% | -$485K | ﹤0.01% | 3051 |
|
|
2020
Q2 | $1.72M | Buy |
19,741
+7,330
| +59% | +$563K | ﹤0.01% | 3018 |
|
|
2020
Q1 | $748K | Sell |
12,411
-17
| -0.1% | -$1.26K | ﹤0.01% | 3610 |
|
|
2019
Q4 | $922K | Buy |
12,428
+747
| +6% | +$48K | ﹤0.01% | 4295 |
|
|
2019
Q3 | $713K | Buy |
11,681
+1,171
| +11% | +$77.1K | ﹤0.01% | 4259 |
|
|
2019
Q2 | $637K | Sell |
10,510
-678
| -6% | -$36.5K | ﹤0.01% | 4114 |
|
|
2019
Q1 | $635K | Buy |
11,188
+8,428
| +305% | +$455K | ﹤0.01% | 3898 |
|
|
2018
Q4 | $116K | Sell |
2,760
-17,584
| -86% | -$748K | ﹤0.01% | 5413 |
|
|
2018
Q3 | $856K | Buy |
20,344
+5,860
| +40% | +$275K | ﹤0.01% | 3990 |
|
|
2018
Q2 | $517K | Buy |
+14,484
| New | +$468K | ﹤0.01% | 4292 |
|
Other funds holding INSP
SCM
DM
UBS Group's INSP Position: Q2 2026 in Review
UBS Group increased its Inspire Medical Systems (INSP) stake by 158% in Q2 2026, buying an estimated $47.7M and bringing the position to 1,645,511 shares worth $73.4M. The position accounts for 0.01% of the portfolio, ranked #1374.
UBS Group first reported a position in INSP in Q2 2018 and has held it in 33 quarters since. The position peaked at $77.3M in Q1 2025. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.
- UBS Group held 1,645,511 shares of Inspire Medical Systems worth $73.4M as of Q2 2026.
- UBS Group bought 1,006,583 Inspire Medical Systems shares in Q2 2026, an estimated $47.7M.
- Inspire Medical Systems made up 0.01% of UBS Group's portfolio in Q2 2026, its #1374 holding.
- UBS Group first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 33 quarters since.
- UBS Group's Inspire Medical Systems position peaked at $77.3M in Q1 2025.
- 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.